New blood-based screening tests for colorectal cancer (CRC) offered fewer benefits at higher cost versus other screening ...

New data showed similar FIT completion rates and yield in younger and older adults, supporting stool-based CRC screening as ...

When given the option, patients ages 45-49 completed colorectal cancer (CRC) screening via fecal immunochemical test (FIT) at ...

Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and ...

It's less widely used than other home methods. Fecal immunochemical test (FIT) This test also looks for small amounts of hidden blood in your poop, using antibodies, which are special proteins ...

One option is the fecal immunochemical test, or FIT, which should be repeated annually. A lab analyzes the sample for traces of blood, which can indicate a polyp or cancer. Large polyps and colon ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

The U.S. Preventive Services Task Force (USPSTF) currently recommends all women get screened for breast cancer every other ...

The Cologuard Plus test also outperformed an independent fecal immunochemical test for overall CRC sensitivity, treatable-stage CRC sensitivity, high-grade dysplasia sensitivity and advanced ...

The test also significantly outperformed an independent fecal immunochemical test for overall colorectal cancer sensitivity, treatable-stage colorectal cancer (stages I-III) sensitivity ...

Results from BLUE-C also show the Cologuard Plus test significantly outperformed an independent fecal immunochemical test for overall CRC sensitivity, treatable-stage CRC (stages I-III ...